StockGlow

Bristol-Myers Squibb Company (BMYB34.SA)

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

323.60-0.00%Healthcare
Compare BMYB34.SA with
StockGlow Score
93
Bullish
BearishBullish
1 year ago+31.8%

The outlook

Bristol-Myers Squibb Company currently reads as bullish based on above its 50- & 200-day averages, 96% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range96% of the way from its 52-week low to high
Market cap
$660.81B
52-wk high
337.49
52-wk low
0.00
50-day avg
294.77
200-day avg
290.07
Trailing P/E
17.6

Similar stocks

PFIZ34.SAPfizer Inc.$31.43-1.63%JNJB34.SAJohnson & Johnson$87.27-3.07%MRCK34.SAMerck & Co., Inc.$82.40-0.50%AMGN34.SAAmgen Inc.$71.85+0.00%ABTT34.SAAbbott Laboratories$44.45-3.37%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy